相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enrichment of Circulating Interleukin-17-Secreting Interleukin-23 Receptor-Positive γ/δ T Cells in Patients with Active Ankylosing Spondylitis
Tony J. Kenna et al.
ARTHRITIS AND RHEUMATISM (2012)
β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice
Merja Ruutu et al.
ARTHRITIS AND RHEUMATISM (2012)
Immunotherapy with PI3K Inhibitor and Toll- Like Receptor Agonist Induces IFN-γ+IL-17+ Polyfunctional T Cells That Mediate Rejection of Murine Tumors
Neil A. Marshall et al.
CANCER RESEARCH (2012)
Th17 Cells in Immunity to Candida albicans
Nydiaris Hernandez-Santos et al.
CELL HOST & MICROBE (2012)
Anti-Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Craig Leonardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS
Ken Flanagan et al.
PLOS ONE (2012)
Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria
Gregory F. Sonnenberg et al.
SCIENCE (2012)
Sensing of mammalian IL-17A regulates fungal adaptation and virulence
Teresa Zelante et al.
NATURE COMMUNICATIONS (2012)
Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation
Ying Li Silvia Innocentin et al.
CELL (2011)
Th17 Cells Mediate Clade-Specific, Serotype-Independent Mucosal Immunity
Kong Chen et al.
IMMUNITY (2011)
Control of TH17 cells occurs in the small intestine
Enric Esplugues et al.
NATURE (2011)
Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
Caroline E. Sutton et al.
IMMUNITY (2009)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi et al.
LANCET (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Kim A. Papp et al.
LANCET (2008)
Interleukin-17 is a negative regulator of established allergic asthma
Silvia Schnyder-Candrian et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis
Caroline Sutton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Transforming growth factor-β induces development of the TH17 lineage
PR Mangan et al.
NATURE (2006)
TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
M Veldhoen et al.
IMMUNITY (2006)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
分享论文
